Lunit (XKRX:328130) ROCE % : -126.52% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lunit ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Lunit's annualized ROCE % for the quarter that ended in Dec. 2024 was -126.52%.

Lunit ROCE % Historical Data

The historical data trend for Lunit's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lunit ROCE % Chart

Lunit Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-80.76

-20.27

-31.76

Lunit Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial											-30.83	-17.29	26.63	-10.84	-126.52

Lunit ROCE % Calculation

Lunit's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-69525.804	/	( ( (267920.7 - 12793.898)	+	(435040.758 - 252412.815) )	/ 2 )
	=	-69525.804	/	( (255126.802	+	182627.943)	/ 2 )
	=	-69525.804	/	218877.3725
	=	-31.76 %

Lunit's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-274496.436	/	( ( (430028.653 - 178755.018)	+	(435040.758 - 252412.815) )	/ 2 )
	=	-274496.436	/	( ( 251273.635	+	182627.943 )	/ 2 )
	=	-274496.436	/	216950.789
	=	-126.52 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Lunit (XKRX:328130) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Lunit ROCE % Related Terms

Thank you for viewing the detailed overview of Lunit's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lunit Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lunit Inc (XKRX:328130) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

374 Gangnam-daero, 4th to 9th Floors, Case Square Gangnam II, Yeoksam-dong, Gangnam-gu, Seoul, KOR, 06241

Website

https://www.lunit.io

Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.

Lunit Headlines

No Headlines